Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S2S Global is a commercial-stage healthcare products and supply chain company that sources and supplies medical, surgical, PPE, and selected foodservice products to healthcare customers. The company focuses on vertically integrated, factory-direct sourcing designed to improve supply chain transparency, resiliency, and cost savings for providers. Its portfolio includes products such as IV catheters, exam gloves, surgical gloves, masks, underpads, air transfer mats, diagnostics, and medication-delivery supplies. Historically operated as Premier's direct sourcing subsidiary, S2S Global entered a strategic ownership transition with Prestige Ameritech in October 2024 and was described as a Prestige Ameritech company by December 2024. The business appears oriented around commercial product supply, private-label offerings, and strategic distribution/manufacturing partnerships rather than drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on S2S Global.